Evidence map›Paper›PMID 42766667›Full record

ArticlePLoS pathogens2026

The pod components of the Shigella T3SS sorting platform accommodate multiple copies of Spa33 (SctQ).

Sean K Whittier, Shoichi Tachiyama, Samira Heydari, Wendy L Picking, Jun Liu, William D Picking

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Sean K WhittierDepartment of Pathobiology and Integrative Biomedical Sciences, University of Missouri, Columbia, Missouri, United States of America.ORCID https://orcid.org/0000-0001-5256-3532
Shoichi TachiyamaDepartment of Microbial Pathogenesis, Yale University, West Haven, Connecticut, United States of America.
Samira HeydariDepartment of Microbial Pathogenesis, Yale University, West Haven, Connecticut, United States of America.
Wendy L PickingDepartment of Pathobiology and Integrative Biomedical Sciences, University of Missouri, Columbia, Missouri, United States of America.
Jun LiuDepartment of Microbial Pathogenesis, Yale University, West Haven, Connecticut, United States of America.
William D PickingDepartment of Pathobiology and Integrative Biomedical Sciences, University of Missouri, Columbia, Missouri, United States of America.

Funding

Characterization of assembly and activation of the Shigella type III secretion injectisomeR01AI172097 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI Jun Liu, WILLIAM D. PICKING · 2022 to 2026
$3.1M
High-throughput electron cryo-microscopeS10OD023603 · OD · YALE UNIVERSITY · PI SIGWORTH, FREDERICK J · 2018 to 2018
$1.9M
NIAID NIH HHS R01 AI172097NIH HHS S10 OD023603
6 · The paper itself

Abstract

The bacterial type III secretion system (T3SS) uses a membrane-embedded injectisome assembly to export effector proteins into host cells. While atomic-level structural details have been revealed for much of the T3SS apparatus, the model of the cytoplasmic sorting platform remains largely low-resolution. A central structural element of the sorting platform is the so-called "pod" protein, SctQ, which anchors the sorting platform to the inner membrane via interaction with the adaptor protein SctK, and connects to the central ATPase via the spoke protein SctL. SctQ proteins also interact with alternatively translated homodimers of their C-terminal SPOA2 domains. Low resolution electron density maps have provided an outline of the sorting platform architecture, and fluorescence microscopy studies have suggested a 1:4:2 SctK:SctQ:SctL stoichiometry. While there are experimental and AlphaFold structures of individual components and complexes of the sorting platform pod, there is currently no model for the pod structure that adequately fits the electron density or accounts for the proposed stoichiometry. Here we use AlphaFold to generate a model of the upper portion of the Shigella pod complex in which two copies of the SctQ protein, Spa33, bind the adaptor protein MxiK, with each copy of Spa33 bound to an alternately translated SPOA2-SPOA2 domain. We show through mutation of energetically critical interface residues, predicted by computational mutant scanning, that both Spa33 binding sites on MxiK are required for T3SS activity in Shigella flexneri, as well as binding of Spa33 to the SPOA2-SPOA2 homodimer. We find that this model fits well to the upper two-thirds of the pod electron density, albeit in a manner that places the protein components slightly closer to the inner membrane than traditionally presented. Further, cryogenic electron tomography shows Spa33/MxiK interface mutant sorting platforms are destabilized and lack clear density for the SctL spoke protein MxiN and central ATPase Spa47, while Spa33/SPOA2-SPOA2 interaction mutants are further disrupted and lack clear lower pod density. The density for the lower portion of the sorting platform pod, thought to arise from Spa33 and MxiN, remains unmodeled, largely due to the inability of AlphaFold to confidently predict the structure of MxiN or MxiN complexes. However, we show that, allowing for potential conformational rearrangements, the pod can accommodate three full-length copies of Spa33 in a manner that fills some of the lower electron density. How a potential fourth copy of Spa33 could occupy the remaining density with MxiN remains unclear.

Indexed as

Bacterial ProteinsShigella flexneriType III Secretion SystemsModels, MolecularProtein TransportBacterial ProteinsType III Secretion Systems

Identifiers

PMID42766667
PMCPMC13614641

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.